Hyderabad: Sigachi Industries Limited, India’s leading manufacturer of pharmaceutical excipients, APIs, and specialty ingredients, has announced the initiation of civil works for its next phase of capacity expansion—an advanced 12,000 MTPA Microcrystalline Cellulose (MCC) project at its Dahej SEZ unit in Gujarat. This strategic move aligns with Sigachi’s long-term vision of operational resilience, safety-first design, and continued global leadership in the excipient industry.
While the investigation committee continues its work on the recent tragedy at Sigachi’s Pashamylaram unit, the Company is actively building forward. The Dahej MCC Project reflects Sigachi’s determination to rise stronger, with smarter systems, globally benchmarked safety features, and capacity augmentation focused on uninterrupted supply to its valued global clientele.
Key Highlights of the Expansion Strategy:
- 12,000 MTPA MCC Capacity to be added at Dahej SEZ, operational within 9 months.
- Designed for Safety & Excellence: The new Spray Dryer system is being procured in
consultation with reputed equipment manufacturers and safety experts.
- Total Installed MCC Capacity will rise to 30,000 MTPA, cementing Sigachi’s position
as the Largest Manufacturer in India and among the top in the world.
- Reinforced Business Continuity: This new capacity at Dahej SEZ, along with increased production at our Jhagadia and Dahej SEZ (existing) facilities, will help us
continue serving our customers without any disruption in supply
Quote from the MD & CEO – Amit Raj Sinha:
“The incident at Pashamylaram was a moment of deep sorrow. Yet, Sigachi stands tall— resolute in our values, committed to learning, and determined to build back stronger. This new capacity at Dahej is a testament to that spirit. It is not just about volumes, but about creating the safest and most reliable excipient manufacturing ecosystem in the world.”
